The future of Liver Transplantation

S Feng, GR Roll, FJ Rouhani, AS Fueyo - Hepatology, 2024 - journals.lww.com
Over the last 50 years, liver transplantation has evolved into a procedure routinely
performed in many countries worldwide. Those able to access this therapy frequently …

Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation

A Esmail, M Badheeb, B Alnahar, B Almiqlash, Y Sakr… - Cancers, 2024 - mdpi.com
Simple Summary Cholangiocarcinoma (CCA) poses a substantial threat as it ranks as the
second most prevalent primary liver tumor. This review reports comprehensively describe …

Advances in Immunotherapy for Transplant Oncology

M Abdelrahim, A Esmail, AR He, M Khushman… - Cancers, 2024 - mdpi.com
The increasing incidence of global cancer rates has created an entirely new demand for
curative treatment modalities to improve patient outcomes. This is evident by the emergence …

Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma

M Abdelrahim, A Esmail, MK Divatia, J Xu… - Journal of Clinical …, 2024 - mdpi.com
Background: Hepatocellular carcinoma (HCC) is widely recognized as the predominant type
of primary liver malignancy. Orthotopic liver transplantation (OLT) has emerged as a highly …

[HTML][HTML] Dd-cfDNA in Liver Transplantation: The Future of Non-Invasive Liver Graft Evaluation

E Avramidou, S Vasileiadou, G Tsoulfas - 2024 - intechopen.com
Donor-derived cell-free DNA (Dd-cfDNA) is a novel biomarker with many diagnostic
applications in various areas of medicine and particularly transplantation. This biomarker is …

Issue preface: living donor liver transplantation

F Di Francesco, S Gruttadauria - European Journal of …, 2024 - eujtransplantation.com
It took more than 20 years before the idea of using a living donor liver graft for orthotopic
liver transplantation, in 1969 1, was realized in clinical practice. The impulse in living donor …